Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
Farnam Barati Sedeh, Mattias A. S. Henning, Gregor B. E. Jemec, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00764-adv00764
Open Access | Times Cited: 24

Showing 24 citing articles:

Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Alexandro Chu, Melanie Wong, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1470-1492
Open Access | Times Cited: 58
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, et al.
Dermatology and Therapy (2025)
Open Access | Times Cited: 2
A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
Mircea Tampa, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 19
An Overview on Atopic Dermatitis, Oxidative Stress, and Psychological Stress: Possible Role of Nutraceuticals as an Additional Therapeutic Strategy
Clara Alessandrello, Serena Sanfilippo, Paola Lucia Minciullo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5020-5020
Open Access | Times Cited: 5
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review
Tiago Torres, Pedro Mendes‐Bastos, Maria João Cruz, et al.
Dermatology and Therapy (2025)
Open Access
Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment
Yung‐Tsu Cho, H.P. Chou, Tom C. Chan, et al.
The Journal of Dermatology (2025)
Closed Access
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
Pedro Mendes‐Bastos, Elizabeth Lazaridou, Tiago Torres, et al.
Dermatology and Therapy (2025)
Open Access
Dermatological Indications: Alopecia Areata
Muazzez Çiğdem Oba, Zekayі Kutlubay
(2025), pp. 83-92
Closed Access
Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions
Alexandra Paolino, Helen Alexander, Conor Broderick, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 5, pp. 495-510
Open Access | Times Cited: 9
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis
Albert C. Chong, Alan Schwartz, Jessica Lang, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S70-S76
Closed Access | Times Cited: 7
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most
Marthe‐Lisa Schaarschmidt, Daniel Kromer, Phoebe Wellmann, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
Albertine Beard, Shannon C. Trotter
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 10, pp. 4128-4134
Open Access | Times Cited: 2
Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance
Jefferson Russo Victor, Dong‐Ho Nahm
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis
Marta Feito Rodríguez, A. Ramírez-Boscá, S. Vidal‐Asensi, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 5, pp. 495-503
Closed Access | Times Cited: 5
Guía de dermatitis atópica para México (GUIDAMEX): lineamientos usando metodología ADAPTE
Désirée Larenas‐Linnemann, Catalina Rincón-Pérez, Jorge A. Luna‐Pech, et al.
Gaceta Médica de México (2023) Vol. 158, Iss. 92
Open Access | Times Cited: 4
Comparative efficacy of systemic treatments for atopic dermatitis in adults
Jenna Sesi, Steven R. Feldman
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 313-320
Closed Access | Times Cited: 4
Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
Jinger Lin, Min Luo, Qianwei Zhuo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Tralokinumab as an Effective Alternative after Dupilumab Treatment Failure in Moderate-to-Severe Atopic Dermatitis: A Real-World Study
Shaina E. George, JiaDe Yu
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. 1228-1230
Closed Access | Times Cited: 1
The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Bader Bashrahil, Ziyad Alzahrani, Sahal Samarkandy, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 3
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 255-266
Closed Access | Times Cited: 2
Treatment of atopic dermatitis with upadacitinib: adcare single center experience
Daria Fomina, Olga A. Мukhina, Valeria I Mikhailova, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Systemic Biologic Management of Atopic Dermatitis
Diem‐Phuong D. Dao, R. Hal Flowers
Advances in experimental medicine and biology (2024), pp. 139-149
Closed Access
Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access
Janus Kinase (JAK) Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis (Eczema): Systematic Review and Network Meta-Analysis
Ming Liu, Ya Gao, Yuan Yuan, et al.
(2024)
Closed Access
Matching-adjusted Indirect Comparison (MAIC) of Tralokinumab Versus Dupilumab for the Treatment of Moderate to Severe Adult Atopic Dermatitis
Tae-Kyung Kim, Keun Soo Shin, Hyojin Kim, et al.
Korean Journal of Clinical Pharmacy (2023) Vol. 33, Iss. 3, pp. 178-185
Open Access
Page 1

Scroll to top